connective tissue diseases

153
CONNECTIVE TISSUE DISEASES Dr. Müge Bıçakçıgil kalaycı Rheumatology department of Yeditepe University Medical Faculty

Upload: ludwig

Post on 23-Feb-2016

80 views

Category:

Documents


0 download

DESCRIPTION

CONNECTIVE TISSUE DISEASES. Dr. Müge Bıçakçıgil kalaycı Rheumatology department of Yeditepe University Medical Faculty. Indroduction. collagen vascular diseases,autoimmune diseases difficult to diagnose – nonspecific symptoms – tend to overlap. Common features: - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: CONNECTIVE  TISSUE DISEASES

CONNECTIVE

TISSUE DISEASES

Dr. Müge Bıçakçıgil kalaycı

Rheumatology department of Yeditepe University Medical Faculty

Page 2: CONNECTIVE  TISSUE DISEASES

Indroduction collagen vascular

diseases,autoimmune diseases

difficult to diagnose– nonspecific symptoms– tend to overlap

Page 3: CONNECTIVE  TISSUE DISEASES

Common features:

1. Host and genetic predisposition – familial occurrence, female preponderance

2. Overlapping clinical features 3. Blood vessel as important target

organ – vasculitis, vasculopathy4. Immunologic correlates – circulating

Ig, immune complexes

Page 4: CONNECTIVE  TISSUE DISEASES

The Immune System:

- designed to protect the host from invading pathogens

(non-self or foreign pathogens) and to eliminate

disease. - Lymphocytes: play a key role, has receptors to

monitor these antigens- exquisitely responsive to invading pathogens

while retaining the capacity to recognize self

antigens

Page 5: CONNECTIVE  TISSUE DISEASES

Autoimmunity

- arises when the body mounts an immune response against itself due to failure to distinguish self tissues and cells from foreign (non-self) antigens.

- Primary mechanisms involved in pathogenesis is unclear

Page 6: CONNECTIVE  TISSUE DISEASES

Autoimmune diseases

Characterized by production of:a) autoantibodies that react with host tissueb) Immune effector T cells that are

autoreactive to endogenous self-peptides

Tissue Injury

Page 7: CONNECTIVE  TISSUE DISEASES

common histiologic feature– inflammatory damage CT and blood vessels– fibrinoid material deposition

Page 8: CONNECTIVE  TISSUE DISEASES

Major groups of connective tissuedisease

• Systemic lupus erythematosus (SLE)• Antiphospholipid syndrome (primary or

secondary)• Systemic sclerosis (scleroderma)• Polymyositis and dermatomyositis• Sjögren's syndrome (primary and

secondary)• Miscellaneous (Mixed CTD,

undifferentiated CTD)

Page 9: CONNECTIVE  TISSUE DISEASES

Systemic Lupus Erythematosus

(SLE)

Page 10: CONNECTIVE  TISSUE DISEASES

Systemic Lupus Erythematosus(SLE)

Chronic multisystemic disease of autoimmune origin

Characterized by flare-ups and remissions

Characteristically affects skin and joints, although any system can be involved

Page 11: CONNECTIVE  TISSUE DISEASES

- prototype autoimmune disease- unknown etiology- production of Ab to components of the cell nucleus

Systemic Lupus Erythematosus (SLE)

Page 12: CONNECTIVE  TISSUE DISEASES

Predominantly occurs in womens

F/M : 9/1 Prevalence -1/1000 to 1/10.000

Onset is usually after puberty (20s-30s)

More commonin African Americans than whites

Page 13: CONNECTIVE  TISSUE DISEASES

Clinical Features Constitutional symptoms:

Fatique, fever, malaise, weigth loss

Low grade fever-active SLE

Rarely 39.5 C-(possible infection)

Page 14: CONNECTIVE  TISSUE DISEASES

Muco-cutaneous Skin Rashes (55-90%)

Photosensitivity to sunlight

Malar rash-’butterfly rash’ fixed erythema, edema in sun-exposed areas(nose and cheeks)sparing the nasolabial fold

Page 15: CONNECTIVE  TISSUE DISEASES

Discoid rash- erythematous patches with kerototic scaling

Maculopapular eruptions- face,V-of the neck,forearms

Page 16: CONNECTIVE  TISSUE DISEASES

Photosensitivity

Butterfly facial rash

Page 17: CONNECTIVE  TISSUE DISEASES

Systemic lupus erythematosus: butterfly rash

Page 18: CONNECTIVE  TISSUE DISEASES
Page 19: CONNECTIVE  TISSUE DISEASES
Page 20: CONNECTIVE  TISSUE DISEASES

Raynaud’s phenomenon(20-60%) Peripheral extremity changes induced

by cold and may be complicated by digital ulcers

Livedoreticularis

Bullous and blistering lesions

Page 21: CONNECTIVE  TISSUE DISEASES

Cutaneous vasculitis

Nailfold capillary changes

Alopecia

Ulcers in nose and mouth (20-50%)

Page 22: CONNECTIVE  TISSUE DISEASES

Raynaud’sphenomenon

Livedo reticularis

Page 23: CONNECTIVE  TISSUE DISEASES

Alopeciadiffuse or patchy

Page 24: CONNECTIVE  TISSUE DISEASES
Page 25: CONNECTIVE  TISSUE DISEASES

Mucosal ulcers

Sicca symptoms- secondary Sjogren’s syndrome

Page 26: CONNECTIVE  TISSUE DISEASES
Page 27: CONNECTIVE  TISSUE DISEASES

Vasculitis

Page 28: CONNECTIVE  TISSUE DISEASES
Page 29: CONNECTIVE  TISSUE DISEASES

Systemic lupus erythematosus: hands, interarticular dermatitis

Page 30: CONNECTIVE  TISSUE DISEASES

Musculoskelatal Jaccoud arthropathy is the term for

the nonerosive hand deformities This may mimic rheumatoid arthritis (RA) ulnar deviation and phalangeal subluxations.

Small-joint arthritis of the hands and wrists is most frequent

Myositis rarely occurs and is more commonly related to overlap syndromes or corticosteroid-induced myopathy.

Page 31: CONNECTIVE  TISSUE DISEASES

Synovitis and Jaccoud’s arthropathy

Page 32: CONNECTIVE  TISSUE DISEASES

Renal involvement

The kidney is the most commonly involved visceral organ in SLE.

Glomerular disease usually develops within the first few years after onset.

Page 33: CONNECTIVE  TISSUE DISEASES

Acute nephritic disease may manifest as hypertension and hematuria.

Nephrotic syndrome may cause edema, weight gain, or hyperlipidemia.

Acute or chronic renal failure may cause symptoms related to uremia and fluid overload.

Page 34: CONNECTIVE  TISSUE DISEASES

consider biopsy if:Proteinuria > 0.5 g/24 hoursred or white cells in urinecasts creatinine clearance reduced

(<80ml/min)

Page 35: CONNECTIVE  TISSUE DISEASES
Page 36: CONNECTIVE  TISSUE DISEASES

Neuropsychiatric Headache is the most common neurological

symptom Mood disorders-anxiety and depression Cognitive disorders Psychosis, Delirium Seizures Stroke and transient ischemic attack (TIA) may

be related to vasculitis. Aseptic meningitis may occur.

Page 37: CONNECTIVE  TISSUE DISEASES

Cardiac Pericarditis that manifests as chest pain is

the most common cardiac manifestation of SLE and may occur with or without a detectable pericardial effusion.

Libman-Sacks endocarditis is noninfectious but may manifest with symptoms similar to those of infectious endocarditis.

Myocarditis may occur in SLE with heart failure symptomatology.

Page 38: CONNECTIVE  TISSUE DISEASES

Pericarditis commonest

Cardiac manifestations

Page 39: CONNECTIVE  TISSUE DISEASES
Page 40: CONNECTIVE  TISSUE DISEASES

Pulmonary features pneumonitis/fibrosis or haemorrhage

pleurisy commonestconsider also PEand infection

pulmonary hypertension

Page 41: CONNECTIVE  TISSUE DISEASES

Hematologic abnormalities

oleucopenia,

olymphopenia,

oAnemia (hemolytic anemia)

othrombocytopenia

Page 42: CONNECTIVE  TISSUE DISEASES

Diagnosis Diagnosis based on the clinical

findings and laboratory evidence.

Screening laboratory studies to diagnose possible SLE should include:

CBC count with differential- help to screen for leucopenia, lymphopenia, anemia, and thrombocytopenia

serum creatinine

Page 43: CONNECTIVE  TISSUE DISEASES

urinalysis with microscopy/ urine protein proteinuria ,hematuria, casts, or pyuria.

ANA

inflammatory markers.

Complement levels: C3 and C4 levels are often depressed in patients with active SLE

Page 44: CONNECTIVE  TISSUE DISEASES

ANA Antinuclear antibody

is an autoantibody against a part of the nucleus

Frequent ANA patterns Speckled Homogeneous /

Diffuse Nucleolar Rim / Peripheral Centromere

Page 45: CONNECTIVE  TISSUE DISEASES

In patients with high clinical suspicion or high ANA titers, additional testing is indicated.

Antinuclear antibodies (ANAs) - Higher titers generally more specific (>1:160)

This may include anti–double-stranded DNA (dsDNA)antibodies, complement, and ANA subtypes such as anti-Smith (Sm) antibodies

, SSA, SSB, and ribonucleoprotein (RNP)

Page 46: CONNECTIVE  TISSUE DISEASES

The following are autoantibody tests used in SLE diagnosis: ANA - Screening test; sensitivity 95%; not

diagnostic without clinical features Anti-dsDNA - High specificity; sensitivity

only 70%; level variable based on disease activity

Anti-Sm - Most specific antibody for SLE; only 30-40% sensitivity

Page 47: CONNECTIVE  TISSUE DISEASES

Anti-SSA (Ro) or Anti-SSB (La) - Present in 15% of patients with SLE and Sekonder Sjögren syndrome; associated with neonatal lupus

Anti-RNP - may indicate mixed connective tissue disease with overlap SLE, scleroderma, and myositis

Page 48: CONNECTIVE  TISSUE DISEASES

antiphospholipid antibodies (anticardiolipin immunoglobulin G [ACA IgG] or immunoglobulin M [ACA IgM] or lupus anticoagulant)

biologic false-positive serologic test results for syphilis

Anti-histone - Drug-induced lupus (DIL) ANA antibodies often this type (eg, with procainamide or hydralazine; minocycline)

Page 49: CONNECTIVE  TISSUE DISEASES

Classification criteria for diagnosis of SLE (>4 of 11)

Malar rash Discoid rash Photosensitivity Oral ulcers Arthritis Serositis Renal disorder

proteinuria > 0.5g cells &/or casts

Neurological disorder seizure or psychosis

Haematologic disorder haemolytic anaemia leukopenia,

lymphopenia thrombocytopenia

Immunological disorder anti-DNA, anti-Sm anti-cardiolipin

ANA positivity

Page 50: CONNECTIVE  TISSUE DISEASES

Treatment Guided by the individual patient's

manifestations.

avoid sun exposure

Fever, rash, musculoskeletal, and serositis manifestations - hydroxychloroquine and NSAIDS. Low-to-moderate–dose steroids are necessary for acute flares.

Page 51: CONNECTIVE  TISSUE DISEASES

CNS involvement and renal disease- high-dose steroids and other immunosuppression agents such as cyclophosphamide, azathioprine, or mycophenolate.

Traditionally, class IV diffuse proliferative lupus nephritis has been treated with aggressive cyclophosphamide induction therapy.

Page 52: CONNECTIVE  TISSUE DISEASES

Antiphospholipid antibody syndrome

Page 53: CONNECTIVE  TISSUE DISEASES

Antiphospholipid antibody syndrome Recurrent venous thrombosis

deep vein thrombosis pulmonary embolus

Recurrent arterial thrombosis myocardial infarction stroke (cerebro-vascular accident)

Recurrent miscarriages

Page 54: CONNECTIVE  TISSUE DISEASES

Antiphospholipid antibody syndrome (APS) Half are associated with SLE Occurs in 10-20% of SLE patients often livedo reticularis, low platelets

Page 55: CONNECTIVE  TISSUE DISEASES
Page 56: CONNECTIVE  TISSUE DISEASES

Antiphospholipid antibody syndrome (APS) Positive tests may include

Lupus anticoagulant (false prolongation of PTT)

Anticardiolipin antibody (aCL) or other antiphospholipid antibodies

False positive VDRL Anti beta 2 glikoprotein Igm, Ig g

Page 57: CONNECTIVE  TISSUE DISEASES

APS Treatment varies on symptoms and

signs ASA or LMW heparin in pregnancy Warfarin if DVT ASA and possibly warfarin if CVA

Page 58: CONNECTIVE  TISSUE DISEASES

Sjögren’s Syndrome

Page 59: CONNECTIVE  TISSUE DISEASES

Sjögren’s syndrome A slowly progressive inflammatory

disease affecting primarily the exocrine glands- especially the salivary and lacrimal glands

İnfiltration of Lymphocyte, plasma cells, and macrophages into target tissues.

Autoantibodies-Anti SS-A (Ro) and anti SS-B (La)

Page 60: CONNECTIVE  TISSUE DISEASES

HLA –DR3 and HLA DR4-development and the severity

Enviromental factors (eg; viral or retroviral infections)

Hormonal factors

Page 61: CONNECTIVE  TISSUE DISEASES

Female gender ( %90 )

30-40 years

Primary or secondary (Rheumatoid arthritis, Systemic lupus erythematosus, Scleroderma)

Page 62: CONNECTIVE  TISSUE DISEASES
Page 63: CONNECTIVE  TISSUE DISEASES

The decrease in exocrine gland secretions seen in SS results in dryness that can affect every mucocutaneous surface of the body

The Sicca Complex Xerostomia- xerophthalmia

Page 64: CONNECTIVE  TISSUE DISEASES

Clinical Features Oral: Burning and dryness of oral mucosal

surfaces Difficult to chew or swallow Atrophy of lingual papillae fissures of tongue and lips Oral candidiasis

Page 65: CONNECTIVE  TISSUE DISEASES

Bilateral parotid and submandibular gland enlargement, pain , and tenderness

Bacterial infections of the major salivary glands

Page 66: CONNECTIVE  TISSUE DISEASES
Page 67: CONNECTIVE  TISSUE DISEASES

Ocular: Gritty or sandy discomfort and the

sensation of a foreign body in the eye

Photophobia

Ocular infections

Page 68: CONNECTIVE  TISSUE DISEASES
Page 69: CONNECTIVE  TISSUE DISEASES

Cutaneous

Dry skin with chronic scaling and pruritus

Leucocytoclastic vasculitis –petechiae or palpable purpura

Page 70: CONNECTIVE  TISSUE DISEASES
Page 71: CONNECTIVE  TISSUE DISEASES

Nasal Decreased smell and attenuation in

the ability to taste food Dryness of sinus-acute or chronic

sinusitis

Vaginal Pain, pruritus dyspareunia and

recurrent vaginal candidiasis dysuria

Page 72: CONNECTIVE  TISSUE DISEASES
Page 73: CONNECTIVE  TISSUE DISEASES

Musculoskelatal

İnflammatory,symmetric,nonerosive,arthralgic syndrome that affects small proksimal joints

Fibromyalgia

Proksimal muscle weakness

Page 74: CONNECTIVE  TISSUE DISEASES

Pulmonary

Tracheobronchial dryness –chronic dry cough

The lymphocytic infiltration of tracheobronchial tree-signs and symptoms of acute and chronic obstructive pulmonary disease

Page 75: CONNECTIVE  TISSUE DISEASES

Restrictive lung disease-infiltration of the pulmonary interstitium

Lymphocytic interstitial pneumonitis

Fibrosing alveolitis, pulmonary vasculitis

Pleuritis

Rare but potentially fatal complication

Page 76: CONNECTIVE  TISSUE DISEASES

Gastrointestinal

Upper esophageal dysphagia

Reflux esophagitis

Acute and chronic pancreatitis

Page 77: CONNECTIVE  TISSUE DISEASES

Chronic active hepatitis and primary biliary cirrhosis

Chronic atrophic gastritis

Pernicious anemia

Lymphocytic colitis and mal absorbtions

Page 78: CONNECTIVE  TISSUE DISEASES

Renal

Chronic lymphocytic interstitial nephritis –common extraglandular complication

Decreased urinary concentrating ability, glycosuria, potassium wasting

Page 79: CONNECTIVE  TISSUE DISEASES

Renal tubular asidosis (hypercalciuria and nephrolithiasis)

Membranous glomerulonephritis

(immune complex accumulation)

Page 80: CONNECTIVE  TISSUE DISEASES

Diagnosis

Laboratory Findings: Autoantibodies develop in most

patients RF (90%)

ANA(80%-usually speckled pattern)

SS-A(Ro) (%60), SS-B(La) (%30)

Page 81: CONNECTIVE  TISSUE DISEASES

Polyclonal hypergammaglobulinemia

ESR elevated

Anemia, leucopenia, thrombocytopenia, elevated circulating immune complexes

cryoglobulinemia

Page 82: CONNECTIVE  TISSUE DISEASES

Diagnosis

Characteristic autoantibodies - Ro, La

Salivary flow (<1,5 mL in 15 minutes)

Salivary gland Sintigraphy-decreased uptake and release of 99m Tc-pertechnetate

Page 83: CONNECTIVE  TISSUE DISEASES

schirmer’s test-<5 mm –positive

Rose bengal staining-detects damage to the conjunctival epithelium

-red spot areas1+(sparsely scattered)2+(densely scattered)3+ (coursely) in 3 different areas of the eye

Total of three areas are added(>4 is abnormal)

Page 84: CONNECTIVE  TISSUE DISEASES
Page 85: CONNECTIVE  TISSUE DISEASES
Page 86: CONNECTIVE  TISSUE DISEASES

Minor salivary gland biopsy Single most specific and sensitive

test

Biopsi graded according to their focus scores

The number of foci of 50 or more mononuclear per 4mm2 of salivary gland tissue

Page 87: CONNECTIVE  TISSUE DISEASES

Revised International Classification Criteria for Sjögren syndromeI-Ocular symptomsII-Oral symptomsIII-Ocular signs(schirmer test,Rose Bengal

score)IV-HistopathologyV- Salivary gland

involvement(sialometri,salivary scintigraphy

VI-autoantibodies 4 of 6 criteria-IV or VI positive3 of 4 objective criteria

Page 88: CONNECTIVE  TISSUE DISEASES

Treatment

symptomatic• oral fluid intake• saliva substitutes• artificial tears

avoid• decongestants• antihistamines• diuretics• anticholinergic

Page 89: CONNECTIVE  TISSUE DISEASES

Treatment

Parasympathomimetic agents pilocarpine , cevimeline

clotrimazole/nystatin

close dental care

Page 90: CONNECTIVE  TISSUE DISEASES

ArthritisNSAIDsHydroxychloroquine

Interstitial lung disease, renal disase, or vasculitis- High dose glucocorticoids or cytotoxic therapy (azathioprine,methotrexate,mycophenolate mofetil, cyclosporine, cyclophosphamid)

surveillance for malignancy

Page 91: CONNECTIVE  TISSUE DISEASES

Systemic sclerosis / scleroderma

Page 92: CONNECTIVE  TISSUE DISEASES

Systemic sclerosis / scleroderma Pathophysiology

Auto-immune disease

Unknown aetiology

Generalised disorder of CT affecting skin (scleroderma) and internal organs

Page 93: CONNECTIVE  TISSUE DISEASES

Characterised by fibrotic arteriosclerosis of peripheral and visceral vasculature

Extracellular matrix accumulation (collagen) in skin and viscera

Associated with specific auto-antibodies

Page 94: CONNECTIVE  TISSUE DISEASES

Epidemiology Rare 3-5 x more common in women Presents in middle age (30-50 yrs)

Page 95: CONNECTIVE  TISSUE DISEASES

Systemic sclerosis / scleroderma

Signs and symptoms

Skin on hands/feet/face affected Sclerodactyly

edema fingers and hands

Page 96: CONNECTIVE  TISSUE DISEASES
Page 97: CONNECTIVE  TISSUE DISEASES
Page 98: CONNECTIVE  TISSUE DISEASES

Sclerodactyly

Page 99: CONNECTIVE  TISSUE DISEASES

Scleroderma: acrosclerosis

Page 100: CONNECTIVE  TISSUE DISEASES
Page 101: CONNECTIVE  TISSUE DISEASES

skin thickeningCharacteristic appearance

Beaked noseFixed expressionRadial furrowing of lipsLimitation of mouth

movements-decreased mouth opening

Accompanying telangiectasia, calcinosis, Raynaud’s

Page 102: CONNECTIVE  TISSUE DISEASES
Page 103: CONNECTIVE  TISSUE DISEASES
Page 104: CONNECTIVE  TISSUE DISEASES
Page 105: CONNECTIVE  TISSUE DISEASES
Page 106: CONNECTIVE  TISSUE DISEASES
Page 107: CONNECTIVE  TISSUE DISEASES
Page 108: CONNECTIVE  TISSUE DISEASES
Page 109: CONNECTIVE  TISSUE DISEASES
Page 110: CONNECTIVE  TISSUE DISEASES

Clinical Features

Calcinosis Digital Ulceration

Page 111: CONNECTIVE  TISSUE DISEASES
Page 112: CONNECTIVE  TISSUE DISEASES
Page 113: CONNECTIVE  TISSUE DISEASES

visceral manifestations

GI tract, lung, kidneys

arthralgias and muscle weakness often

Page 114: CONNECTIVE  TISSUE DISEASES
Page 115: CONNECTIVE  TISSUE DISEASES

dysphagia

• 80% distal 2/3pathology• decrease/absentparistalsis, dilation,hiatal hernia

Page 116: CONNECTIVE  TISSUE DISEASES
Page 117: CONNECTIVE  TISSUE DISEASES
Page 118: CONNECTIVE  TISSUE DISEASES

widespread skin thickening are at the greatest risk of visceral involvement, which may include the heart, lungs, kidneys or gastrointestinal system

Raynaud’s phenomenon is almost always apparent at presentation in patients with the CREST syndrome and in about 70% of patients with diffuse disease.

Page 119: CONNECTIVE  TISSUE DISEASES

SclerodermaCREST

Page 120: CONNECTIVE  TISSUE DISEASES
Page 121: CONNECTIVE  TISSUE DISEASES
Page 122: CONNECTIVE  TISSUE DISEASES

Systemic sclerosis (scleroderma)

Diagnosis Clinical

Specific auto-antibodies

Page 123: CONNECTIVE  TISSUE DISEASES

positive ANA with a nucleolar pattern

Anti-centromere antibodies are found in 50 to 95% of patients with CREST syndrome, but only in about 10% of patients with diffuse scleroderma and visceral disease.

Page 124: CONNECTIVE  TISSUE DISEASES

Scl-70 and PM-Scl. Scl-70 (DNA topoisomerase I).

Antibodies to Scl-70 are detected in some patients with diffuse scleroderma.

Antibodies to PM-Scl are seen in some patients with “sclerodermatomyositis,” an overlap of inflammatory myositis and scleroderma.

ESR, anemia, hypergammaglobulinemia, RF

Page 125: CONNECTIVE  TISSUE DISEASES

Organ specific investigations A chest x-ray pulmonary function tests fibrosing alveolitis- interstitial fibrosis -

diffuse skin involvement isolated pulmonary hypertension-CREST

syndrome. A barium swallow - esophageal dysmotility,

reflux or esophageal stricture. Nailfold capillary microscopy

Page 126: CONNECTIVE  TISSUE DISEASES

Treatment– symptomatic• calcium channel blockers in Raynaud’s• H2 blockers for reflux• NSAIDS and steroids for arthralgias and myalgias• hand rehabPulmonary involvement- pulse

cyclophosphamid

Page 127: CONNECTIVE  TISSUE DISEASES

POLYMYOSİTİS &

DERMATOMYOSİTİS

Page 128: CONNECTIVE  TISSUE DISEASES

– group of disorders– proximal muscle weakness– nonsuppurative inflammation skeletal Muscle

• prevalence 5 cases/mil/year• 2 to 1 F>M• 40-60 yrs• pediatric variant 5-15-yrs

Page 129: CONNECTIVE  TISSUE DISEASES

Myositis can be associated with malignancy

Polymyositis begins insidiously over 3-6 months

Pelvic and shoulder musculature are most affected.

Page 130: CONNECTIVE  TISSUE DISEASES

Esophagial dysfunction or cricopharyngeal obstruction cause dysphagia.

Myalgias, artralgias are common but severe muscle tenderness and sinovitis are unusual

Raynoud phenomenon

Periorbital edema

Page 131: CONNECTIVE  TISSUE DISEASES

Pulmonary and cardiac manifestations may precede the onset of muscle weakness

Supraventricular arrhytmia, cardiomyopathy and congestive heart failure

İnterstitial fibrosis or interstitial pneumonitis

Page 132: CONNECTIVE  TISSUE DISEASES
Page 133: CONNECTIVE  TISSUE DISEASES

Clinical classification of the inflamatory myopathies Polymyositis Dermatomyositis Juvenile dermatomyositis myositis associated with neoplasia myositis associated with collagen

vascular disease Inclusion body myositis

Page 134: CONNECTIVE  TISSUE DISEASES
Page 135: CONNECTIVE  TISSUE DISEASES
Page 136: CONNECTIVE  TISSUE DISEASES
Page 137: CONNECTIVE  TISSUE DISEASES
Page 138: CONNECTIVE  TISSUE DISEASES
Page 139: CONNECTIVE  TISSUE DISEASES
Page 140: CONNECTIVE  TISSUE DISEASES
Page 141: CONNECTIVE  TISSUE DISEASES
Page 142: CONNECTIVE  TISSUE DISEASES
Page 143: CONNECTIVE  TISSUE DISEASES
Page 144: CONNECTIVE  TISSUE DISEASES
Page 145: CONNECTIVE  TISSUE DISEASES

Vasculitis

Ectopic calcification ( sc. tissue,muscle)

Vasculitis cause gastrointestinal ulcerations, hemorrhage or perforation

Page 146: CONNECTIVE  TISSUE DISEASES
Page 147: CONNECTIVE  TISSUE DISEASES
Page 148: CONNECTIVE  TISSUE DISEASES

Dermatomyositis sine myositis

Dermatomyositis sine myositis

Biopsi confirmed classical cutaneous findings of dermatomyositis

Motor function, muscle enzyme, EMGs are normal

İncreased prevalence of neoplasia

Page 149: CONNECTIVE  TISSUE DISEASES
Page 150: CONNECTIVE  TISSUE DISEASES

Diagnosis Laboratory findings Elevated creatine kinase (CK) CK levels correlates with disease activity Aldolase, aspartate aminotransferase

(AST) Alanine aminotransferase (ALT) LDH ESR- 50%-N

Page 151: CONNECTIVE  TISSUE DISEASES

ANA-50%

Most myositis specific autoantibodies are directed against amino acyl-t RNA synthetase activities (anti Jo-1)

Anti –Mi-2- directed against helicase activities

Anti SRP- signal recognition particle

Page 152: CONNECTIVE  TISSUE DISEASES
Page 153: CONNECTIVE  TISSUE DISEASES